Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This is a placebo-controlled study with a duration of 72 weeks (83)
Eli Lilly, the maker of Mounjaro and Zepbound, is urging the court to impose stricter diagnostic proof requirements in the ongoing GLP-1 gastroparesis litigation
The German company paid $55 million upfront and agreed to more than $1 billion in potential milestone payments to get ex-China rights for a bispecific antibody by Biotheus
Proposals were advanced to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulk drug substances list, further limiting large-scale production
Many people find that they help make periods lighter and less painful, and research shows they may reduce the risk of uterine, ovarian, and colon cancer
